On May 20, U.S. Food and Drug Administration ( FDA) officials announced that Covid-19 vaccines will no longer be available to everyone. Instead, annual boosters will be limited to people ages 65 and ...

For groups younger than 65 or without specific chronic conditions, postmarketing trials will be needed to open access.

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

A new study from Kennedy Krieger Institute is calling attention to an emerging mental health crisis among children with long COVID. Researchers found that nearly 40% of pediatric patients with long ...

In a recent study, a research team from the Medical University of Vienna has gained new insights into post-COVID syndrome ...

Federal officials unveiled a rigorous regulatory approach to future COVID vaccines that could make it harder for many people ...

In this week’s edition of InnovationRx, we look at the FDA's new rules on Covid-19 vaccines, Novartis’s acquisition strategy, ...

Earlier this month, the US government announced a US$500 million (£377 million) investment to accelerate research into ...

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

New data suggests India's true COVID-19 death toll may be seven times higher than official figures, raising questions about ...

Rather, it is the complex interactions between pupil absence and exclusions, the ongoing impacts on children with special ...